The duration and safety of osteoporosis treatment [electronic resource] : anabolic and antiresorptive therapy / Stuart Silverman, Bo Abrahamsen, editors.
Silverman, Stuart, editor.; Abrahamsen, Bo, editor.
2016
RC931.O73
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title The duration and safety of osteoporosis treatment [electronic resource] : anabolic and antiresorptive therapy / Stuart Silverman, Bo Abrahamsen, editors.
ISBN 9783319236391 (electronic book)
3319236393 (electronic book)
9783319236384
3319236385
DOI https://doi.org/10.1007/978-3-319-23639-1
Published Cham : Springer, 2016.
Language English
Description 1 online resource (xvi, 338 pages) : illustrations.
Item Number 10.1007/978-3-319-23639-1 doi
Call Number RC931.O73
Dewey Decimal Classification 616.7/1606
Summary Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and future pharmaceuticals. Leading practitioners in the field examine all current literature and data regarding the duration and safety of these therapies, with recommendations for clinicians on decision-making and best practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture risk assessment and an examination of treatment failures. Next, a number of chapters are dedicated to the diagnosis, presentation and management of atypical femur fractures and osteonecrosis of the jaw (ONJ), each of which are significant patient concerns when using these osteoporosis treatments. The introduction and utilization of drug holidays is also discussed, as well as the long-term outlook for management of osteoporotic patients. Written and edited by experts in the field, The Duration and Safety of Osteoporosis Treatment is a balanced resource for researchers, practitioners and policy-makers alike for clinical decision-making and patient care.
Note Includes index.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed January 11, 2016).
Added Author Silverman, Stuart, editor.
Abrahamsen, Bo, editor.
Available in Other Form Print version: 9783319236384
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Foreword
Preface
Osteoporosis: Pathophysiology & Epidemiology
Antiresorptives
Anabolics
Tools for Assessing Fracture Risk and for Treatment Monitoring
Treatment Failure
Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures
Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features
Factors Contributing to Atypical Femoral Fractures
Clinical Presentation of Atypical Femur Fractures
Effects of Antiresorptive Therapy on Bone Microarchitecture
Management of Atypical Femoral Fractures
Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features
Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment
Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment
Long-Term Efficacy and Safety of Treatments for Osteoporosis
Management of Drug Holidays
Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant?
Fractures and Healing on Antiresorptive Therapy
Antiresorptive Therapy and Mortality and Cancer Incidence
Other Safety Concerns
The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making
Integrated Clinical View on Long-Term Management of Patients with Osteoporosis
Conclusions.

Browse Subjects

Show more subjects...

Statistics

from
to
Export